Results 1 to 10 of about 455,273 (283)

Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia

open access: yesFrontiers in Immunology, 2022
BackgroundIschemic stroke is one of the leading causes of human death and disability. Brain edema and peri-infarct astrocyte reactivity are crucial pathological changes, both involving aquaporin-4 (AQP4).
Chengfeng Sun   +8 more
doaj   +2 more sources

Pharmaceutical Cocrystal Development of TAK-020 with Enhanced Oral Absorption

open access: yesCrystals, 2020
The objective of this study was to improve the solubility of poorly water-soluble drugs by pharmaceutical cocrystal engineering techniques and select the best pharmaceutical forms with high solubility and solubilized formulations for progress from the ...
Kouya Kimoto   +6 more
doaj   +2 more sources

Correlation of TGN-020 with the analgesic effects via ERK pathway activation after chronic constriction injury

open access: yesMolecular Pain, 2018
Extracellular regulated protein kinase (ERK) pathway activation in astrocytes and neurons has been reported to be critical for neuropathic pain development after chronic constriction injury.
Liang Zhao   +8 more
doaj   +2 more sources

Optical coherence tomography guided targeted non-viral optical delivery of opsin-encoding genes into the retina [PDF]

open access: yesFrontiers in Pharmacology
IntroductionRetinal degenerative diseases cause progressive photoreceptor loss while leaving populations of inner retinal neurons available for optogenetic intervention.
Sanghoon Kim   +5 more
doaj   +2 more sources

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial

open access: yesJournal of Clinical Oncology, 2023
PURPOSE Nivolumab and relatlimab activity in advanced melanoma with prior progression on anti–programmed death-1/programmed death ligand 1 (PD-(L)1)-containing regimens is under investigation.
P. Ascierto   +21 more
semanticscholar   +1 more source

TGN-020 Alleviate Inflammation and Apoptosis After Cerebral Ischemia–Reperfusion Injury in Mice Through Glymphatic and ERK1/2 Signaling Pathway

open access: yesMolecular Neurobiology, 2023
Post-stroke acute inhibition of aquaporin 4 (AQP4) is known to exacerbate inflammation and apoptosis, yet the underlying mechanisms are not fully understood.
Xiaohong Li   +11 more
semanticscholar   +1 more source

ANALISIS PEMAHAMAN GURU TERHADAP GAYA BELAJAR SISWA DI SDN 020 RIDAN PERMAI

open access: yesJurnal review pendidikan dasar. Jurnal kajian pendidikan dan hasil penelitian, 2022
This research was motivated by the importance of teacher's role in understanding students’ characteristics such as learning styles. This research was aimed to describe the teachers' understanding on students’ learning styles, learning profiles, services ...
Dina Hafizha   +2 more
semanticscholar   +1 more source

A Novel Methodology for Developing Troubleshooting Chatbots Applied to ATM Technical Maintenance Support

open access: yesApplied Sciences, 2023
The banking industry has been employing artificial intelligence (AI) technologies to enhance the quality of its services. More recently, AI algorithms, such as natural language understanding (NLU), have been integrated into chatbots to improve banking ...
Nádila Azevedo   +9 more
doaj   +1 more source

The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer

open access: yesCancers, 2022
Simple Summary Colorectal cancer (CRC) is generally diagnosed at an advanced stage, when chemo- and targeted therapies can only achieve a limited increase in overall survival for these patients.
Bo Kang   +9 more
semanticscholar   +1 more source

A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Rising‐Dose Study of the BTK Inhibitor TAK‐020 in Healthy Subjects

open access: yesClinical and Translational Science, 2021
Bruton’s tyrosine kinase (BTK) is a target for treatment of hematologic malignancies and autoimmune diseases. TAK‐020 is a highly selective covalent BTK inhibitor that inhibits both B cell receptor and fragment crystallizable receptor signaling.
Ehsanollah Esfandiari   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy